Postbiotica | Admin
POSTBIOTICA is an innovative Biopharmaceutical Company born to develop a new therapeutic treatments based on new molecules with a high biological impact called POSTBIOTICS. We hold a new fermentative process in which we design e modulate the Postbiotics productions.
postbiotica, postbiotics, postbiotics productions, biopharmaceutical company
3
archive,author,author-umberto,author-3,ajax_fade,page_not_loaded,,qode-theme-ver-16.7,qode-theme-bridge,wpb-js-composer js-comp-ver-5.5.2,vc_responsive
 

Author: Admin

The project “L’onda Covid: capire per reagire”, a cycle of conferences with internationally renowned Italian scientists coordinated by the magazine of the University of Padova “Il Bo Live” to approach the Genoa Science Festival, hosted Prof. Maria Rescigno, Head of Mucosal Immunology and Microbiota Unit...

The work of the Mucosal and Microbiota Immunology Laboratory directed by Prof. Maria Rescigno at Humanitas Research Hospital and supported by the AIRC foundation, led to the publication in Nature Microbiology of the paper regarding the identification of endogenous antitumor bacterial strains. The results show...

Postbiotica has signed a licensing agreement with Kalichem(a Lamberti company) leader in the dermocosmetic market, based on a well established R&D collaboration.   Kalichem develops and commercializes functional ingredients for cosmetics and medical devices. The agreement relates to the licensing of Postbtiocs-based products, obtained through our...

Postbiotica has signed a licensing and commercialising agreement with Candioli Pharma, a company leader in the pet-care market. The agreement foresees the exclusivity of the postbiotic ImmunoFOS® as an active ingredient to develop innovative nutraceuticals for pet healthcare. Thanks to this partnership Postbiotica aims to expand...